Get started
Author

Ferran Vall‐Llovera

Observed names: F Vall-Llovera, F. Vall-Llovera, F. Vall-llovera, Ferran Vall-LLovera, Ferran Vall-Llovera, Ferran Vall-llovera, Ferran Vall‐llovera, Ferrand Ferran Vall-Llovera, Ferrán Vall-Llovera, Ferrán Vall-llovera
Observed institutions: Hospital Universitari Arnau de Vilanova, University Hospital Mútua de Terrassa, Institut Català d'Oncologia, Hospital Arnau de Vilanova, Mútua Terrassa, Hospital Universitari Germans Trias i Pujol, Hospital Universitario Ramón y Cajal
ORCID: 0000-0002-0718-5955
Observed ORCID: 0000-0002-0718-5955
OpenAlex ID: A5063204016
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia
2020 · Josep-Maria Ribera, Mireia Morgades, et al. · Blood · 87
Dose‐intensive chemotherapy including rituximab in Burkitt's leukemia or lymphoma regardless of human immunodeficiency virus infection status
2013 · Josep‐Maria Ribera, Olga García, et al. · Cancer · 70
PDF
European LeukemiaNet 2017 risk stratification for acute myeloid leukemia: validation in a risk-adapted protocol
2021 · Alex Bataller, Ana Garrido, et al. · Blood Advances · 55
Unique clinico-biological, genetic and prognostic features of adult early T-cell precursor acute lymphoblastic leukemia
2019 · Eulàlia Genescà, Mireia Morgades, et al. · Haematologica · 49
Acute myeloid leukemia with NPM1 mutation and favorable European LeukemiaNet category: outcome after preemptive intervention based on measurable residual disease
2020 · Alex Bataller, Guadalupe Oñate, et al. · British Journal of Haematology · 48
PDF
Different methylation signatures at diagnosis in patients with high-risk myelodysplastic syndromes and secondary acute myeloid leukemia predict azacitidine response and longer survival
2021 · CETLAM group, M. Cabezón, et al. · Clinical Epigenetics · 44
PDF
Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia
2022 · A. Luna, L. Pérez-Lamas, et al. · Annals of Hematology · 41
Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients
2014 · Blanca Xicoy, Josep-Maria Ribera, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 38
Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry Experience
2022 · Jorge Labrador, Miriam Saiz-Rodríguez, et al. · Cancers · 32
Drug-to-drug interactions of tyrosine kinase inhibitors in chronic myeloid leukemia patients. Is it a real problem?
2018 · On behalf of the CML Spanish Group (GELMC), Santiago Osorio, et al. · Annals of Hematology · 28
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort
2023 · Guadalupe Oñate, Marta Pratcorona, et al. · Blood Cancer Journal · 26
PDF
Decrease in the frequency of meningeal involvement in AIDS-related systemic lymphoma in patients receiving HAART
2007 · J.-T. Navarro, F. Vall-Llovera, et al. · Haematologica · 25
PDF
Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)
2021 · Eulàlia Genescà, Mireia Morgades, et al. · Leukemia Research · 24
PDF
A pediatric regimen for adolescents and young adults with Philadelphia chromosome‐negative acute lymphoblastic leukemia: Results of the ALLRE08 PETHEMA trial
2020 · Josep‐Maria Ribera, Mireia Morgades, et al. · Cancer Medicine · 21
Impact of mutational studies on the diagnosis and the outcome of high-risk myelodysplastic syndromes and secondary acute myeloid leukemia patients treated with 5-azacytidine
2018 · Marta Cabezón, the CETLAM Group, et al. · Oncotarget · 19
PDF
Efficacy and safety of native versus pegylatedEscherichia coliasparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia
2017 · Josep-Maria Ribera, Mireia Morgades, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 19
Increased survival due to lower toxicity for high‐risk T‐cell acute lymphoblastic leukemia patients in two consecutive pediatric‐inspired PETHEMA trials
2018 · Pere Barba, Mireia Morgades, et al. · European Journal Of Haematology · 15
PDF
Outcomes and prognostic factors of adults with refractory or relapsed T‐cell acute lymphoblastic leukemia included in measurable residual disease‐oriented trials
2021 · Josep‐Maria Ribera, Mireia Morgades, et al. · Hematological Oncology · 14
Comparison of intensive, pediatric-inspired therapy with non-intensive therapy in older adults aged 55–65 years with Philadelphia chromosome-negative acute lymphoblastic leukemia
2018 · Josep-Maria Ribera, Olga García, et al. · Leukemia Research · 14
Genomics improves risk stratifi cation of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials
2022 · Celia González-Gil, Mireia Morgades, et al. · Haematologica · 13
PDF
Using the Lymph2Cx assay for assessing cell-of-origin subtypes of HIV-related diffuse large B-cell lymphoma
2018 · Maria Joao Baptista, Gustavo Tapia, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 12
Post-Remission Treatment with Chemotherapy or Allogeneic Hematopoietic Stem Cell Transplantation (alloHSCT) of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-neg) Adult Acute Lymphoblastic Leukemia (ALL) According to Minimal Residual Disease (MRD). Preliminary Results of the Pethema ALL-HR-11 Trial
2015 · Josep-Maria Ribera, Mireia Morgades, et al. · Blood · 12
Clinical outcomes after CPX ‐351 in patients with high‐risk acute myeloid leukemia: A comparison with a matched cohort from the Spanish PETHEMA registry
2023 · Teresa Bernal, Ainhoa Fernández Moreno, et al. · Cancer Medicine · 9
PDF
Application of a digital PCR method for WT1 to myeloid neoplasms in CR and deep ELN WT1 molecular response (< 10 copies)
2020 · E. Bussaglia, M. Pratcorona, et al. · Annals of Hematology · 9
Enterocolitis neutropénica en adultos con leucemia aguda o receptores de un trasplante de progenitores hematopoyéticos: estudio de 7 casos
2007 · Montserrat Batlle, Ferran Vall-Llovera, et al. · Medicina Clínica · 9
Works count: 75
Citation count: 824
H-index: 16
I10-index: 22
Year
Topic
Type